Astressin, a corticotropin releasing factor antagonist, reverses the anxiogenic effects of urocortin when administered into the basolateral amygdala
- 11 September 2000
- journal article
- Published by Elsevier in Brain Research
- Vol. 877 (2) , 226-234
- https://doi.org/10.1016/s0006-8993(00)02638-x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stressNature Genetics, 2000
- Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2Nature Genetics, 2000
- Effect of urocortin on ACTH secretion from rat anterior pituitary in vitro and in vivo: comparison with corticotropin-releasing hormoneBrain Research, 1998
- Bidirectional Synaptic Plasticity in the Rat Basolateral Amygdala: Characterization of an Activity-Dependent Switch Sensitive to the Presynaptic Metabotropic Glutamate Receptor Antagonist 2S-α-Ethylglutamic AcidJournal of Neuroscience, 1998
- Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behaviorRegulatory Peptides, 1997
- Neurotransmission in the rat amygdala related to fear and anxietyTrends in Neurosciences, 1994
- In vivo kindling does not alter afterhyperpolarizations (AHPs) following action potential firing in vitro in basolateral amygdala neuronsBrain Research, 1992
- Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?Brain Research Reviews, 1990
- Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic studyJournal of Neuroscience, 1985
- The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugsJournal of Neuroscience Methods, 1980